UAB Experts on H1N1 Swine Flu

Key points
- The University of Alabama at Birmingham (UAB) has several experts who can address the spread of the novel H1N1 influenza virus, also called swine flu.
- Whitley, UAB’s Director of Pediatric Infectious Disease, has been tapped by U.S.
- Kimberlin is a professor of pediatric infectious diseases and co-director of UAB’s Division of Pediatric Infectious Diseases.
- Gnann is a professor in the UAB Division of Infectious Diseases and medical director of the UAB 1917 Clinic.
The University of Alabama at Birmingham (UAB) has several experts who can address the spread of the novel H1N1 influenza virus, also called swine flu.
PANDEMIC PREPAREDNESS, PUBLIC PERSPECTIVE
Richard Whitley, M.D.
Whitley, UAB’s Director of Pediatric Infectious Disease, has been tapped by U.S. President Barack Obama to serve on the H1N1 influenza working group of the President’s Council of Advisors on Science and Technology (PCAST). A professor of pediatrics, microbiology and neurosurgery, Whitley serves as vice-chair of the Department of Pediatrics and as co-director of UAB’s Center for Emerging Infections and Emergency Preparedness. Whitley is also president-elect of the Infectious Diseases Society of America.
Expertise: Flu-infection projections, government preparedness, drug stockpiling, common-sense prevention and self-care tips for the public.
H1N1 VACCINE TESTING AND DELIVERY, FLU PREVENTION
David Kimberlin, M.D.
Kimberlin is a professor of pediatric infectious diseases and co-director of UAB’s Division of Pediatric Infectious Diseases. He is one of four U.S. physicians serving on the federal Safety Monitoring Committee reviewing clinical trials of H1N1 vaccines. The committee is a part of the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases (NIAID). Kimberlin also oversees all pediatric studies conducted by the NIAID Collaborative Antiviral Study Group, and he is a member of the American Academy of Pediatrics Committee on Infectious Diseases. Kimberlin is associate editor of the academy’s Red Book, a revered pediatric treatment manual.
Expertise: Flu prevention, managing flu symptoms in children, adults and at-risk populations, H1N1 vaccine testing.
ANTIVIRAL THERAPY, FLU-CARE INSTRUCTION
John Gnann Jr., M.D.
Gnann is a professor in the UAB Division of Infectious Diseases and medical director of the UAB 1917 Clinic. He is a noted researcher in vaccines to prevent human infection, development of new drugs to treat viral infection and the mechanisms of viral resistance to antiviral drugs. Gnann also oversees all adult studies conducted by the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
Expertise: Antiviral resistance, the prevention of flu infection.
INTERNATIONAL FLU SURVEILLANCE, TRAVEL MEDICINE
David Freedman, M.D.
Freedman is a professor in the UAB Division of Infectious Diseases and director of the UAB Travelers’ Clinic. A noted expert in the development of disease surveillance networks for travelers and migrants, Freedman is co-director of the GeoSentinel surveillance project, a network of 48 travel- and tropical-medicine units on several continents supported by the U.S. Centers for Disease Control and Prevention and the International Society of Travel Medicine.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsChina experts design gel to protect women from HIV
Scientists in China and Hong Kong are designing a gel containing an experimental drug, which they hope can reduce HIV infections in women. The search for such a prophylaxis is gaining urgency in China with sex becoming…
2 October 2010
NewsH1N1 flu virus can mutate in immunosuppressed patients-study
Patients with suppressed immune systems can quickly develop H1N1 flu infections that resist all known drugs, doctors in the Netherlands reported on Wednesday. The case of a 5-year-old leukemia patient who died from…
2 October 2010
NewsExperts give low marks for AIDS prevention efforts
Only 10 percent of countries have HIV prevention programmes that are well matched to their national needs, leaving millions at risk of contracting the incurable virus, AIDS scientists said on Tuesday. The Global HIV…